[Nonmydriatic stereoscopic retinal imaging for retinal condition]
Hernández-Vásquez A, García Martí S, Pichon-Riviere A, Augustovski F, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L
Record ID 32017000280
Spanish
Authors' recommendations:
No good quality studies assessing nonmydriatic stereoscopic retinal scan versus mydriatic retinal scan were found on retinal conditions. There is more evidence on the use of nonmydriatic stereoscopic retinal imaging in diabetic retinopathy, suggesting this would not be better than mydriatic retinal retinography as screening method.
The main clinical practice guidelines recommend retinal retinography use with pharmacological mydriasis as screening and follow-up method for diabetic retinopathy and one considers nonmydriatic stereoscopic retinal imaging as an alternative, whose disadvantage is its high cost.
Most United States health coverage policies found generally cover induced mydriatic retinal retinography to document disease-related abnormalities and as follow-up of patients with macular degeneration, diabetic retinopathy, glaucoma, retinal neoplasms, among others. However they consider it experimental and at investigational stage as screening method.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Humans
- Retina
- Retinal Diseases
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.